Welcome to our dedicated page for CREDO TECHNOLOGY GROUP HOLDING SEC filings (Ticker: CRDO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Debugging 400G SerDes margins or tracking wafer supply clauses in Credo’s disclosures can consume hours. Each CRDO report packs dense semiconductor jargon, multi-jurisdictional risk factors, and complex royalty tables. If you’ve searched for “Credo Technology insider trading Form 4 transactions” or wondered how to interpret the next “Credo Technology quarterly earnings report 10-Q filing,” you know the challenge.
Stock Titan solves it. Our AI reads every submission the moment it hits EDGAR, then delivers plain-English answers to the queries investors actually type—“understanding Credo Technology SEC documents with AI,” “Credo Technology annual report 10-K simplified,” or “Credo Technology 8-K material events explained.” Dynamic summaries spotlight where SerDes licensing lifts gross margin, flag covenant changes, and link directly to supporting page numbers. Need immediate alerts? “Credo Technology Form 4 insider transactions real-time” are streamed within seconds so you can monitor executive stock transactions before the market digests them.
Use the platform to:
- Compare segment revenue trends across consecutive 10-Qs and access Credo Technology earnings report filing analysis without spreadsheets.
- Review Credo Technology proxy statement executive compensation data to evaluate incentive alignment with hyperscale design-win milestones.
- Capture context on capital-intensive fab commitments via 8-K and S-3 filings.
Whether you’re screening “Credo Technology executive stock transactions Form 4” or dissecting power-efficiency claims buried in a 300-page 10-K, our expert commentary, AI-powered summaries, and real-time updates turn complex semiconductor filings into actionable insight—no advanced RF engineering degree required.
The Bank of Nova Scotia (BNS) is offering $1,057,000 of Buffered Enhanced Participation Basket-Linked Notes maturing July 7, 2027. The unsecured senior notes provide no periodic interest and their value at maturity is entirely linked to the performance of a weighted equity basket: EURO STOXX 50 (38%), TOPIX (26%), FTSE 100 (17%), Swiss Market Index (11%) and S&P/ASX 200 (8%). The initial basket level is 100; the final level is measured on the valuation date of July 5, 2027.
Return profile:
- If the final basket level > initial level, holders receive principal plus 149% participation of the basket’s gain.
- If the basket declines ≤10% (final level ≥90), investors receive full principal (10% buffer).
- If the basket declines >10%, repayment is reduced by approximately 1.1111% for every 1% decline beyond the buffer, exposing investors to up to 100% loss of principal.
The initial estimated value is $968.53 per $1,000 note, below the 100% issue price, reflecting selling commissions (1.50%) and hedging/structuring costs. Proceeds to BNS are 98.5% of face. The notes will not be listed on any exchange; Scotia Capital (USA) Inc. and Goldman Sachs & Co. LLC may make a market but are not obligated.
Key terms:
- Participation rate: 149%
- Buffer level: 90% of initial basket
- Buffer rate: ~111.11%
- Trade date / issue date: Jul 3 2025 / Jul 11 2025 (T+5 settlement)
- Maturity: Jul 7 2027 (≈24 months)
- Denominations: $1,000 and multiples thereof
- Calculation agent: Scotia Capital Inc. (affiliate of issuer)
Risks disclosed: credit risk of BNS; market risk of basket components; lack of liquidity; potential total loss beyond the 10% buffer; issuer’s internal funding rate makes economic terms less favorable than conventional debt; conflicts of interest in hedging and market-making; no dividend participation; currency movements not hedged; initial price exceeds estimated value.
The notes suit investors seeking leveraged upside to a diversified international equity basket, willing to forgo income and accept credit and market risks as well as limited secondary liquidity.
STMicroelectronics (STM) has released a Form 6-K reporting routine activity under its 2024 share-buyback program. During the week of 30 June – 4 July 2025, the company repurchased 202,801 ordinary shares (≈0.02% of issued capital) on Euronext Paris at a weighted-average price of €26.0578, for a total outlay of €5.28 million. Following these purchases, STM now holds 16,724,034 treasury shares, representing about 1.8% of total shares outstanding. The repurchases are executed to satisfy employee equity plans and may be re-allocated for other lawful purposes under EU Market Abuse Regulation article 5(2). No changes to guidance, capital structure strategy, or operational outlook were disclosed.
Structure Therapeutics Inc. (GPCR) – Form 4 filing dated 07/03/2025
Chief Executive Officer and Director Raymond C. Stevens reported several equity transactions in the company’s ordinary shares and American Depositary Shares (ADSs).
- 03/01/2025 – Tax withholding: 12,495 ordinary shares (Code F) were automatically withheld at an average price of $7.9166 to satisfy tax obligations linked to a prior restricted-share-unit (RSU) vesting.
- 07/01/2025 – Performance share vesting: 89,697 ordinary shares (Code A) were credited at $0 after performance criteria on March 2024 PSUs were partially met. On the same day, 16,050 shares were withheld for taxes (Code F, $6.8366).
- 05/21/2025 – Voluntary purchase: Stevens bought 1,000 ADSs (3,000 ordinary-share equivalent) through the company’s Employee Share Purchase Plan (Code A).
Post-transaction ownership
- Direct: 1,194,830 ordinary shares and 1,000 ADSs.
- Indirect (family trust): 1,554,586 ordinary shares and 4,000 ADSs.
The filing indicates continued equity accumulation by the CEO, with the majority of new shares originating from performance-based awards. Disposals were administrative (tax withholding) rather than discretionary sales, limiting negative interpretation.
Huntington Bancshares Inc. (HBANP) – Form 4 filing dated 07/03/2025
Chief Enterprise Payments Officer Amit Dhingra reported routine, plan-based acquisitions on 07/01/2025:
- 592.234 common shares acquired directly at a stated price of $0.00.
- 63.423 common shares acquired indirectly through the Issuer’s Supplemental Stock Purchase and Tax Savings Plan.
Post-transaction ownership stands at 164,738.787 shares held directly and 6,959.05 shares held indirectly via the plan. No dispositions were reported, and no derivative securities were involved.
The filing indicates ongoing participation in company equity plans rather than open-market buying or selling. The amounts are modest relative to the company’s share count and do not, on their own, imply a material change in insider sentiment or corporate outlook.
Wells Fargo & Company (WFC) – Form 4 insider filing
Director Ronald Sargent reported one routine transaction dated 1 Jul 2025. He acquired 490.8578 phantom stock units at a reference price of $81.49 under the company’s deferred-compensation plan (transaction code A). Each unit is economically equivalent to one share of common stock. After the purchase, the director directly owns 67,695.7607 phantom stock units and 81 common shares, plus 18,050 common shares held indirectly through a revocable trust. No derivative sales or option exercises were disclosed. The filing reflects ongoing equity-based compensation and does not signal any operational or strategic change for Wells Fargo.
Monopar Therapeutics (MNPR) – Form 4 insider transaction filed for Chief Operating Officer Andrew Cittadine covering activity on 30 June 2025.
- 6,863 common shares were issued to Cittadine upon the vesting of Restricted Stock Units (RSUs) granted on 2 Feb 2022, 1 Feb 2023 and 4 Mar 2025.
- 2,990 shares were withheld for taxes (transaction code “F”), leaving a net 3,873 new shares.
- Cittadine’s direct common-stock holding after the transactions is 45,858 shares; he also retains 43,001 unvested RSUs.
- No open-market purchases or sales occurred; all activity relates to automatic RSU settlement (transaction code “M”).
The filing indicates a routine equity-compensation event rather than a discretionary purchase. While the COO’s ownership stake increases modestly, the economic outlay is zero; therefore, the signal for outside investors is generally neutral.
Form 4 insider filing – Fiserv, Inc. (FI)
On 30 June 2025, director Charlotte Yarkoni elected to defer US$32,500 of board fees under Fiserv’s Non-Employee Director Deferred Compensation Plan. In exchange, she received 189 deferred-compensation notional units, calculated at the same-day closing share price of $172.41. Each unit represents the right to receive one share of Fiserv common stock after her board tenure ends.
- Transaction code: A (acquisition, non-open-market)
- Units acquired: 189
- Implied value: $32,500
- Post-transaction holdings: 1,100 notional units (direct ownership)
- Settlement: 1-for-1 share conversion upon separation
The filing reports no sales, option exercises, or other derivative activity. Because the transaction stems from fee deferral rather than discretionary share purchases, it does not signal a valuation call, yet it marginally increases equity alignment between the director and shareholders. Given Fiserv’s multibillion-dollar market capitalisation, the dollar value is immaterial to earnings or valuation models and is unlikely to affect trading sentiment. Investors may view the steady use of the deferred-fee program as normal governance practice rather than a catalyst.
ZoomInfo Technologies Inc. (ZI) – Form 144 filing discloses a planned insider sale under Rule 144.
- Securities to be sold: 14,773 Class A common shares.
- Estimated market value: US$148,911.84 (based on prevailing market price cited in the form).
- Seller of record: James M. Roth, acting pursuant to a Rule 10b5-1 trading plan, with Morgan Stanley Smith Barney LLC as broker.
- Planned sale date: on or about 02 July 2025 through NASDAQ.
- Share-count context: ZI reports 328,911,200 shares outstanding; the proposed sale represents ≈0.0045 % of shares outstanding.
- Recent activity: The same insider sold 18,408 shares on 05 June 2025 for gross proceeds of US$184,398.72.
The filing is a routine notice rather than a completed transaction. Given the small size relative to total float, the event is unlikely to be materially impactful for shareholders, but it does provide visibility into insider trading activity and possible sentiment.
Transportadora de Gas del Sur S.A. (TGS) has filed a Form 6-K to announce that the Argentine gas regulator ENARGAS issued Resolution 421/2025, published in the Official Gazette on 1 July 2025, approving new tariff charts for the company.
- Automatic monthly adjustment: Tariffs will now be updated every month using the formula set out in Energy Bureau Resolution 241/2025 and approved by ENARGAS Resolution 350/2025. The formula gives a 50 % weight to the national Consumer Price Index (IPC) and 50 % to the Wholesale Price Index (IPIM). The first application produces a 0.62 % tariff increase.
- Five-year review increase: An additional rise for transportation services is introduced pursuant to Section 5 of ENARGAS Resolution 256/2025. The filing does not state the percentage size of this component.
The company states that these adjustments apply to its regulated gas transportation business and were communicated as a material fact to the Argentine capital markets. No further financial, operational or guidance information was included.
Credo Technology Group (NASDAQ:CRDO) filed a Form 4 revealing that director Lip-Bu Tan sold a total of 92,248 ordinary shares on 24-25 June 2025 at weighted-average prices of $90.00–$93.62, generating roughly $8.4 million in proceeds.
After the transactions, Tan’s direct and indirect ownership decreased to 694,073 shares, a reduction of about 12% from his previous holdings. All sales were executed in multiple tranches, with detailed price breakdowns available upon request. No derivative activity or Rule 10b5-1 trading plan was disclosed. Tan remains a board director and sole reporting person.